Improvement of patient-reported outcomes in severe allergic asthma by omalizumab treatment: the real life observational PROXIMA study

ConclusionThis study demonstrated that in severe allergic asthma, omalizumab improves patient-reported outcomes such as patients ' illness perception and QoL, while confirming improvement of asthma control and exacerbation rate reduction in Italian patients. (Source: World Allergy Organization Journal)

from #Head and Neck by Sfakianakis via simeraentaxei on Inoreader https://ift.tt/2DgpcOV